Vertaling van "major risk " (Nederlands → Frans) :

TERMINOLOGIE

Variola major-virus
virus Variola major

deficiëntie van 'major histocompatibility complex class II'
Déficit en complexe majeur d'histocompatibilité classe II

aften van Bednar | periadenitis mucosa necrotica recurrens | recidiverend ulcus aphthosum | stomatitis aphthosa (major)(minor) | stomatitis herpetiformis
Aphtose de Bednar Périadénite muqueuse nécrotique récidivante Stomatite:aphteuse (majeure) (mineure) | herpétiforme | Ulcération aphteuse récidivante

deficiëntie van 'major histocompatibility complex class I'
Déficit en complexe majeur d'histocompatibilité classe I

Cooley-anemie | thalassaemia | intermedia | thalassaemia | major
Bêta-thalassémie grave Maladie de Cooley Thalassémie:intermédiaire moyenne | majeure

fractuur van trochanter major van femur
fracture du grand trochanter

musculus pectoralis major
structure du muscle grand pectoral

klieren van Bartholin [glandulae vestibulares majores]
Glande de Bartholin

controle van zwangerschap met verhoogd risico [high-risk]
Surveillance d'une grossesse à haut risque

IN-CONTEXT TRANSLATIONS

2 Het betreft volgende velden: PP0010, Major_risk_cat Flag, Minor_risk_cat flag, Major_coverage_yn Flag.
2 Il s’agit des champs suivants: PP0010, Major_risk_cat Flag, Minor_risk_cat flag, Major_coverage_yn Flag.

We are already able to say following the first debriefing that a number of major points were identified within the FAMHP, for instance, our approach to risk management or risk analysis.
We are already able to say following the first debriefing that a number of major points were identified within the FAMHP, for instance, our approach to risk management or risk analysis.

Inhaled anticholinergics and risk of major cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
of major cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Mondillo et al 42 2002 RCT yes 188 Among subjects undergoing major vascular surgery, severity and extent of ischemia during DSE and presence of > 3 reversible perfusion defects are strong predictors of cardiac events particularly in moderate risk patients
Mondillo et al 44 2002 RCT yes 188 Among subjects undergoing major vascular surgery, severity and extent of ischemia during DSE and presence of > 3 reversible perfusion defects are strong predictors of cardiac events particularly in moderate risk patients

26. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery.
25. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery.

AGO178 (agomelatine), a once-daily investigational treatment for patients with major depression, will be studied in additional Phase III trials to further explore the benefit/risk and pharmacokinetic profile of this compound.
AGO178 (agomélatine), un traitement investigationnel par prise unique quotidienne contre la dépression sévère, fera l’objet d’une étude dans le cadre d’essais supplémentaires de phase III afin d’explorer plus avant le profil bénéfice/risque et pharmacocinétique de cette molécule.

Diovan is the only medicine in the ARB class approved to treat the three major cardiovascular indications: high blood pressure, high-risk heart attack and heart failure.
Diovan est le seul médicament de la classe des ARA autorisé pour le traitement de trois indications cardiovasculaires majeures: hypertension, infarctus du myocarde à haut risque et insuffisance cardiaque.

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.
Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic.

Such systematic screening is particularly recommended in units where patients are at high risk of serious MRSA infections (intensive care units, heart surgery, major surgery such as organ transplantation).
Un tel dépistage systématique est en particulier recommandé dans les unités où les patients courent un risque élevé d’infections graves à MRSA (soins intensifs, chirurgie cardiaque, chirurgie majeure telle que la transplantation d'un organe).

Kluytmans J.A.J.W., Mouton J.W., Yzerman E.P.F. et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery.
Kluytmans J.A.J.W., Mouton J.W., Yzerman E.P.F., et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery.